Co-amorphous drug formulations in numbers: Recent advances in co-amorphous drug formulations with focus on co-formability, molar ratio, preparation methods …
Co-amorphous drug delivery systems (CAMS) are characterized by the combination of two
or more (initially crystalline) low molecular weight components that form a homogeneous …
or more (initially crystalline) low molecular weight components that form a homogeneous …
Co-amorphous solid dispersions for solubility and absorption improvement of drugs: Composition, preparation, characterization and formulations for oral delivery
The amorphous solid state offers an improved apparent solubility and dissolution rate.
However, due to thermodynamic instability and recrystallization tendencies during …
However, due to thermodynamic instability and recrystallization tendencies during …
Recent technologies for amorphization of poorly water-soluble drugs
Amorphization technology has been the subject of continuous attention in the
pharmaceutical industry, as a means to enhance the solubility of poorly water-soluble drugs …
pharmaceutical industry, as a means to enhance the solubility of poorly water-soluble drugs …
Co-amorphous systems for the delivery of poorly water-soluble drugs: Recent advances and an update
J Han, Y Wei, Y Lu, R Wang, J Zhang… - Expert opinion on drug …, 2020 - Taylor & Francis
Introduction Most new drug candidates under development are poorly water-soluble, which
are related to multiple pharmaceutical issues, increasing the bioavailability of these drugs by …
are related to multiple pharmaceutical issues, increasing the bioavailability of these drugs by …
Amino acids and its pharmaceutical applications: A mini review
A Bongioanni, MS Bueno, BA Mezzano… - International Journal of …, 2022 - Elsevier
Amino acids are natural compounds that can be safely used in pharmaceutical applications.
Considering the great interest in the amino acids used in the pharmaceutical industry, this …
Considering the great interest in the amino acids used in the pharmaceutical industry, this …
New approved drugs appearing in the pharmaceutical market in 2022 featuring fragments of tailor-made amino acids and fluorine
The strategic fluorination of oxidatively vulnerable sites in bioactive compounds is a
relatively recent, widely used approach allowing us to modulate the stability, bio-absorption …
relatively recent, widely used approach allowing us to modulate the stability, bio-absorption …
Curcumin: Pharmaceutical solids as a platform to improve solubility and bioavailability
Curcumin (CUR) is the prime curcuminoid in the Indian dietary spice turmeric, Curcuma
longa, a plant of the Zingiberaceae family. CUR has promising and diverse therapeutic …
longa, a plant of the Zingiberaceae family. CUR has promising and diverse therapeutic …
Co-former selection for co-amorphous drug-amino acid formulations
We have previously developed a fast screening method on the ability of twenty amino acids
(AA) to form co-amorphous formulations with six drugs upon ball milling. In this work, the …
(AA) to form co-amorphous formulations with six drugs upon ball milling. In this work, the …
[HTML][HTML] Development, recent advances, and updates in binary, ternary co-amorphous systems, and ternary solid dispersions
A Saberi, M Kouhjani, D Yari, A Jahani… - Journal of Drug Delivery …, 2023 - Elsevier
Binary co-amorphous systems (CAMS) are a type of solid dispersion containing an active
pharmaceutical ingredient (API) and small molecule excipients. The properties of these …
pharmaceutical ingredient (API) and small molecule excipients. The properties of these …
Amino acids as the potential co-former for co-crystal development: a review
I Nugrahani, MA Jessica - Molecules, 2021 - mdpi.com
Co-crystals are one of the most popular ways to modify the physicochemical properties of
active pharmaceutical ingredients (API) without changing pharmacological activity through …
active pharmaceutical ingredients (API) without changing pharmacological activity through …